1-161589571-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000466542.6(FCGR2C):c.143C>T(p.Pro48Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000566 in 1,554,492 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 7/9 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P48T) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000466542.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCGR2C | NR_047648.1 | n.242C>T | non_coding_transcript_exon_variant | 3/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCGR2C | ENST00000466542.6 | c.143C>T | p.Pro48Leu | missense_variant | 3/7 | 1 | ENSP00000426627.1 | |||
ENSG00000289768 | ENST00000699402.1 | c.41-40540G>A | intron_variant | ENSP00000514363.1 |
Frequencies
GnomAD3 genomes AF: 0.000293 AC: 42AN: 143480Hom.: 3 Cov.: 28
GnomAD3 exomes AF: 0.0000826 AC: 20AN: 242112Hom.: 1 AF XY: 0.0000994 AC XY: 13AN XY: 130804
GnomAD4 exome AF: 0.0000326 AC: 46AN: 1410892Hom.: 4 Cov.: 37 AF XY: 0.0000356 AC XY: 25AN XY: 701478
GnomAD4 genome AF: 0.000292 AC: 42AN: 143600Hom.: 3 Cov.: 28 AF XY: 0.000300 AC XY: 21AN XY: 69946
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.143C>T (p.P48L) alteration is located in exon 3 (coding exon 3) of the FCGR2C gene. This alteration results from a C to T substitution at nucleotide position 143, causing the proline (P) at amino acid position 48 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at